Developer docs
API playgroundTry for free, no card

Search company profiles

LionBird

Full company profile

uuid0000wqg

Namestring
LionBird
Legal namestring
LionBird (Ventures) Ltd
Websiteurl
lionbird.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

LionBird is a venture capital firm founded in 2012 and headquartered in Tel Aviv, Israel, with a North American office in Evanston, Illinois. The firm invests exclusively in pre-scale digital health startups, providing early-stage capital and hands-on operational support including go-to-market assistance, strategic advisory, warm introductions to downstream investors, and access to senior healthcare operators via its LionBird Rings community. Since inception, LionBird has invested in more than 35 founding teams and manages over $150 million in assets under management, with a claimed 80%+ follow-on financing rate versus a 20% industry benchmark.

The firm's portfolio is concentrated in digital health across multiple sub-verticals, including AI-enabled virtual examination (Tyto Care), healthcare compliance analytics (Protenus, acquired by Thoma Bravo), cancer recurrence monitoring (C2i Genomics, acquired by Veracyte), senior virtual primary care (Heyday Health), elder care navigation (Mellie), behavioral health AI (Jimini Health), federated healthcare AI infrastructure (Rhino Health), and ML-based clinical trial optimization (PhaseV). Notable co-investors across the portfolio include a16z, Khosla Ventures, General Catalyst, Accel, Oak hc/ft, Viola, and UpWest, with strategic content collaborations with TELUS Global Ventures.

LionBird's business model is venture capital returns: the firm generates revenue through management fees on committed capital and carried interest on exits, reserving follow-on funds to support portfolio companies across subsequent financing rounds. The firm operates a relationship-driven, sales-led go-to-market focused on warm introductions, founder referrals, and content-led marketing (LionBird Bites monthly newsletter, LionBird Wings quarterly newsletter, and a library of whitepapers covering IDNs, self-insured employers, hospital SaaS, SNFs, MAOs, and pharma R&D). The team comprises partners with backgrounds spanning Fortune 100 healthcare operations (Ed Michael, former EVP at Abbott Laboratories), prior VC and operating experience (Gal Noyman Veksler, ex-aMoon and NeuroLabs AI), and serial entrepreneur exits (Chaim Friedman, STARLIMS IPO and Abbott acquisition; Robert Lord, Protenus co-founder).

Short descriptiontext

LionBird is a Tel Aviv- and Evanston-based venture capital firm founded in 2012 that invests exclusively in pre-scale digital health startups, managing over $150 million in AUM across 35+ portfolio companies. It provides early-stage capital, GTM support, and access to a healthcare executive network through its LionBird Rings community.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTel Aviv, Israel
HQ citystring
Tel Aviv
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, digital health investing, pre-seed funding, early-stage healthcare, startup capital markets
Industry1 code
PRIMARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)
NAICS code2 codes
  • Funds, Trusts, and Other Financial Vehicles525
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital / Digital Health Investment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Returns
TypeLicensing Royalties
Description

LionBird generates returns through equity investments in early-stage digital health companies. The firm takes equity stakes in portfolio companies and realizes returns through exits via acquisitions or public offerings. They reserve follow-on funds to invest in future capital requirements.

lionbird.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1LionBird Bites
Description

Monthly newsletter aggregating digital health news and insights, read by VC industry professionals

lionbird.com
+1 more record
Core offering1 text field

LionBird is a venture capital firm that invests exclusively in pre-seed to seed-stage digital health startups, providing pre-scale capital alongside hands-on operational support, including go-to-market strategy, strategic advisory, warm introductions to downstream institutional investors, and access to a community of healthcare executives (LionBird Rings). It has invested in more than 35 founding teams and manages over $150 million in assets under management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 80%+ of LionBird's initial investments attract significant institutional-led follow-on financing (vs 20% industry average)
+1 more record
Product overview1 text field

LionBird is a venture capital firm investing exclusively in pre-scale digital health companies. Since its inception, the firm has invested in more than 35+ founding teams and now has over $150 million in AUM. Rather than operating a software product business, LionBird provides pre-scale capital, strategic guidance, and operational support to healthcare technology startups. The firm offers investment services, founder resources (including whitepapers, cheat sheets on market segments like SNF, MAO, IDN, and self-insured employers), networking opportunities through LionBird Rings (a community of healthcare executives), and educational content via the LionBird Bites newsletter. LionBird does not develop or sell its own software products or platforms.

Product and service1 record
1Pre-Scale Venture Capital Investment
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

TELUS Global Ventures collaborated with LionBird on the Women's Health whitepaper/report, with Managing Partner Terry Doyle providing endorsement and Ravit Warsha Dor as co-author.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Early- and growth-stage healthcare and fintech investor that has co-invested with LionBird in Black Ore; a natural peer in digital health specialization.

TypeDirect peer
Description

Healthcare technology-focused early-stage VC supporting founders building innovative solutions for the healthcare ecosystem; directly comparable pre-seed/seed digital health investor.

TypeDirect peer
Description

Consumer-focused digital health early-stage investor with operator support model, similar vertical specialization and stage to LionBird.

TypeDirect peer
Description

Early-stage digital health specialist VC investing across providers, payors, and healthcare IT, closely comparable to LionBird's pre-scale digital health thesis and stage focus.

TypeBroad incumbent
Description

Large multi-stage VC with a dedicated health practice that has co-invested with LionBird in Ecton; similar stage overlap in digital health seed deals but operates a much larger fund platform.

TypeBroad incumbent
Description

Corporate venture arm of UnitedHealth's Optum focused on digital health and care delivery; invests across stages as a strategic partner rather than as a pure financial VC.

TypeDirect peer
Description

Healthcare-focused VC that co-invested with LionBird in the Jimini Health seed round; comparable healthcare-only specialist mandate.

TypeDirect peer
Description

Early-stage investor in healthcare IT and cybersecurity; similar pre-seed/seed healthcare technology orientation.

TypeDirect peer
Description

Digital health-specific early-stage operator-led VC; an investor comparable to LionBird on focus, stage, and operator support model.

TypeBroad incumbent
Description

Generalist Tier-1 VC with a dedicated Bio/Health fund that has co-invested with LionBird in Black Ore; broader franchise but overlapping digital health deal flow at the seed stage.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment75 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LionBird

Venture Capital / Digital Health Investmentlionbird.com

LionBird is a Tel Aviv- and Evanston-based venture capital firm founded in 2012 that invests exclusively in pre-scale digital health startups, managing over $150 million in AUM across 35+ portfolio companies. It provides early-stage capital, GTM support, and access to a healthcare executive network through its LionBird Rings community.

What LionBird does

LionBird is a venture capital firm founded in 2012 and headquartered in Tel Aviv, Israel, with a North American office in Evanston, Illinois. The firm invests exclusively in pre-scale digital health startups, providing early-stage capital and hands-on operational support including go-to-market assistance, strategic advisory, warm introductions to downstream investors, and access to senior healthcare operators via its LionBird Rings community. Since inception, LionBird has invested in more than 35 founding teams and manages over $150 million in assets under management, with a claimed 80%+ follow-on financing rate versus a 20% industry benchmark.

The firm's portfolio is concentrated in digital health across multiple sub-verticals, including AI-enabled virtual examination (Tyto Care), healthcare compliance analytics (Protenus, acquired by Thoma Bravo), cancer recurrence monitoring (C2i Genomics, acquired by Veracyte), senior virtual primary care (Heyday Health), elder care navigation (Mellie), behavioral health AI (Jimini Health), federated healthcare AI infrastructure (Rhino Health), and ML-based clinical trial optimization (PhaseV). Notable co-investors across the portfolio include a16z, Khosla Ventures, General Catalyst, Accel, Oak hc/ft, Viola, and UpWest, with strategic content collaborations with TELUS Global Ventures.

LionBird's business model is venture capital returns: the firm generates revenue through management fees on committed capital and carried interest on exits, reserving follow-on funds to support portfolio companies across subsequent financing rounds. The firm operates a relationship-driven, sales-led go-to-market focused on warm introductions, founder referrals, and content-led marketing (LionBird Bites monthly newsletter, LionBird Wings quarterly newsletter, and a library of whitepapers covering IDNs, self-insured employers, hospital SaaS, SNFs, MAOs, and pharma R&D). The team comprises partners with backgrounds spanning Fortune 100 healthcare operations (Ed Michael, former EVP at Abbott Laboratories), prior VC and operating experience (Gal Noyman Veksler, ex-aMoon and NeuroLabs AI), and serial entrepreneur exits (Chaim Friedman, STARLIMS IPO and Abbott acquisition; Robert Lord, Protenus co-founder).

LionBird firmographics

Firmographics
Name
LionBird
Legal name
LionBird (Ventures) Ltd
Website
https://lionbird.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
LionBird is a Tel Aviv- and Evanston-based venture capital firm founded in 2012 that invests exclusively in pre-scale digital health startups, managing over $150 million in AUM across 35+ portfolio companies. It provides early-stage capital, GTM support, and access to a healthcare executive network through its LionBird Rings community.
Ownership category
akta.pro rank

LionBird industry classification

Industry
Product category
Venture Capital / Digital Health Investment
NAICS
Funds, Trusts, and Other Financial Vehicles (525), Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)

Keywords

  • Venture capital investing
  • Digital health investing
  • Pre-seed funding
  • Early-stage healthcare
  • Startup capital markets

Where LionBird is headquartered

Location

Headquarters

HQ city
Tel Aviv
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

LionBird business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Venture Capital Returns: LionBird generates returns through equity investments in early-stage digital health companies. The firm takes equity stakes in portfolio companies and realizes returns through exits via acquisitions or public offerings. They reserve follow-on funds to invest in future capital requirements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

LionBird product offering

Product offering

Core offering

LionBird is a venture capital firm that invests exclusively in pre-seed to seed-stage digital health startups, providing pre-scale capital alongside hands-on operational support, including go-to-market strategy, strategic advisory, warm introductions to downstream institutional investors, and access to a community of healthcare executives (LionBird Rings). It has invested in more than 35 founding teams and manages over $150 million in assets under management.

Product overview

LionBird is a venture capital firm investing exclusively in pre-scale digital health companies. Since its inception, the firm has invested in more than 35+ founding teams and now has over $150 million in AUM. Rather than operating a software product business, LionBird provides pre-scale capital, strategic guidance, and operational support to healthcare technology startups. The firm offers investment services, founder resources (including whitepapers, cheat sheets on market segments like SNF, MAO, IDN, and self-insured employers), networking opportunities through LionBird Rings (a community of healthcare executives), and educational content via the LionBird Bites newsletter. LionBird does not develop or sell its own software products or platforms.

Differentiator

Problem solved

Functional benefit

Brands

  • LionBird Bites: Monthly newsletter aggregating digital health news and insights, read by VC industry professionals
  • LionBird Wings

Products and services

  • Pre-Scale Venture Capital Investment

Quantifiable outcome

  • 80%+ of LionBird's initial investments attract significant institutional-led follow-on financing (vs 20% industry average)
  • +1 more outcomes

Companies that use LionBird

Customer profile

Named customers8 records

Segments1 record

Ideal customer profiles1 record

LionBird technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

LionBird partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • TELUS Global VenturescoreStrategic or Co-development PartnerTELUS Global Ventures collaborated with LionBird on the Women's Health whitepaper/report, with Managing Partner Terry Doyle providing endorsement and Ravit Warsha Dor as co-author.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

LionBird competitors and assessment

Company assessment

Direct peers

  • Oak HC/FT: Early- and growth-stage healthcare and fintech investor that has co-invested with LionBird in Black Ore; a natural peer in digital health specialization.
  • Flare Capital Partners: Healthcare technology-focused early-stage VC supporting founders building innovative solutions for the healthcare ecosystem; directly comparable pre-seed/seed digital health investor.
  • 7wireVentures: Consumer-focused digital health early-stage investor with operator support model, similar vertical specialization and stage to LionBird.
  • Define Ventures: Early-stage digital health specialist VC investing across providers, payors, and healthcare IT, closely comparable to LionBird's pre-scale digital health thesis and stage focus.
  • Town Hall Ventures: Healthcare-focused VC that co-invested with LionBird in the Jimini Health seed round; comparable healthcare-only specialist mandate.
  • .406 Ventures: Early-stage investor in healthcare IT and cybersecurity; similar pre-seed/seed healthcare technology orientation.
  • Define Health Ventures: Digital health-specific early-stage operator-led VC; an investor comparable to LionBird on focus, stage, and operator support model.

Broad incumbents

  • General Catalyst: Large multi-stage VC with a dedicated health practice that has co-invested with LionBird in Ecton; similar stage overlap in digital health seed deals but operates a much larger fund platform.
  • Optum Ventures: Corporate venture arm of UnitedHealth's Optum focused on digital health and care delivery; invests across stages as a strategic partner rather than as a pure financial VC.
  • Andreessen Horowitz (a16z Bio/Health Fund): Generalist Tier-1 VC with a dedicated Bio/Health fund that has co-invested with LionBird in Black Ore; broader franchise but overlapping digital health deal flow at the seed stage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

LionBird social profiles

Digital presence

LionBird financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LionBird leadership team

Management profile

Number of profiles

Profiles10 records

LionBird funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LionBird M&A and investment

M&A and investment

M&A

Investments75 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LionBird

What does LionBird do?

LionBird is a venture capital firm that invests exclusively in pre-seed to seed-stage digital health startups, providing pre-scale capital alongside hands-on operational support, including go-to-market strategy, strategic advisory, warm introductions to downstream institutional investors, and access to a community of healthcare executives (LionBird Rings). It has invested in more than 35 founding teams and manages over $150 million in assets under management.

Is LionBird a public or private company?

LionBird is a private company. It is classified as management employee owned and is currently operating.

When was LionBird founded?

LionBird was founded in 2012. It employs 11 to 50 people.

Where is LionBird based?

LionBird is headquartered in Tel Aviv, Israel, in the Middle East region.

How does LionBird make money?

One revenue line is on record: venture Capital Returns.

Who are LionBird's main competitors?

Direct peers on record are Oak HC/FT, Flare Capital Partners, 7wireVentures, Define Ventures, Town Hall Ventures, .406 Ventures and Define Health Ventures. Broad incumbents are General Catalyst, Optum Ventures and Andreessen Horowitz (a16z Bio/Health Fund).

Does LionBird have an API?

No public API is recorded for LionBird.

What industry is LionBird in?

LionBird's product category is Venture Capital / Digital Health Investment. Its primary akta.pro industry code is FSANAAAA, Early-Stage Venture Capital (Pre-Seed/Seed). Its NAICS code is 525 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
//telecareaware.com/Funding/deal roundup: WHOOP’s $575M Giant raise, Anthropic buys med AI startup for $400M, early stage fundings for Jimini, Insight Health; Noom buys compounder; Mount Sinai NY to embed OpenEvidenceWHOOP raised $575 million in Series G funding, valuing the fitness wearable at $10.1 billion. Anthropic acquired bio-research software firm Coefficient Bio for $400 million in stock. Other deals include Jimini Health's $17 million seed round and Noom's acquisition of a compounding pharmacy.San Diego Business JournalPatient Partner Raises $7.5M to Expand its Platform ReachPatient Partner, a digital health platform focused on connecting patients with similar health issues, has raised $7.5 million in funding, led by LionBird and including investments from FCA Venture Partners and others. The startup plans to use this capital to enhance its technology and expand its reach among new patient populations and healthcare verticals. The funding round marks the second institutional round for the 7-year-old company, highlighting increased investor confidence in innovative healthcare solutions.AlleyWatchThe AlleyWatch Startup Daily Funding Report: 4/24/2023Katmai Tech raised $22 million in venture funding led by Starr Insurance Companies, while Chiefy secured $4.2 million in seed funding led by LionBird for its collaboration platform. These deals were reported as part of the daily startup funding updates for New York City startups on April 24, 2023.PR NewswireDr. Peter Pronovost joins the LionBird Rings communityLionBird, a venture capital firm investing in pre-scale digital health companies with operations in Israel and the U.S., announced that Dr. Peter Pronovost has joined as a senior advisor to their LionBird Rings community, which connects proven executives with portfolio companies. Dr. Pronovost is a renowned patient safety expert known for his checklist-based protocols that reduced catheter-related bloodstream infections, earning him recognition including being named one of Time Magazine's 100 most influential people and receiving a MacArthur Foundation grant. In his advisory role, he will assist portfolio companies with strategy, commercial development, and operations.TechloyLionBird launches an $85 million fund to support US-focused healthcare startups in the Middle EastLionBird, an Israel-based venture capital firm, partnered with Al Waha Fund of Funds to launch an $85 million fund targeting US-focused healthcare startups in the Middle East and North Africa. Al Waha, launched in 2018, has deployed over $80 million to 11 funds. The partnership aims to support startups in Bahrain and the Gulf Cooperation Council in navigating the US healthcare market.FinSMEsLionBird Closes $85M Digital Health-Focused FundLionBird closed its $85M LionBird III fund, supported by institutional investors including HOOPP. The fund will invest in 15-20 early-stage digital health companies, and the firm added two partners, Robert Lord and Gal Noyman-Veksler.PR NewswireLionBird closes $85 million digital health-focused fundLionBird closed its third fund, LionBird III, an $85 million digital health-focused fund with institutional investor participation. The fund will invest in 15 to 20 early-stage companies, and the team expanded with two new partners.AxiosLionBird closes $85M fundLionBird, a digital health VC firm, closed its third fund at $85 million, its largest to date. The fund will back 15-18 health tech startups, with two new partners joining. It is nearly three times the size of its second fund and more than four times its first.PR NewswireNeurotechnology Startup Phantom Neuro Secures $3.26M Seed Round from LionBird Ventures, Draper Associates & Breakout Ventures to Advance Machine Control TechnologyPhantom Neuro, a neurotechnology startup, announced a $3.26 million seed round led by LionBird Ventures with participation from Draper Associates, Breakout Ventures, and others. LionBird's Robert Lord will join the board, and the company's patent-pending Phantom X technology aims to improve control of robotic prosthetics and exoskeletons.BioSpaceNeurotechnology Startup Phantom Neuro Secures $3.26M Seed Round from LionBird Ventures, Draper Associates & Breakout Ventures to Advance Machine Control TechnologyNeurotechnology startup Phantom Neuro secured a $3.26 million seed funding round led by LionBird Ventures, with participation from Draper Associates, Breakout Ventures, Blackrock Neurotech, and Capital Factory. The company intends to use the capital to advance its patent-pending Phantom X technology, which aims to provide lifelike control for robotic prosthetics and exoskeletons through low-power sensors and AI.